GT Biopharma (GTBP) had the highest return in 2015 by a US stock when the return was <= 197,800%, returning 9,042.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2015 | 9,042.86% |
OrganiGram (OGI) | 2015 | 8,150% |
Eastside Distilling (BLNE) | 2015 | 7,995.95% |
SurgePays (SURG) | 2015 | 4,400% |
Cidara Therapeutics (CDTX) | 2015 | 2,045% |
GreenPro Capital (GRNQ) | 2015 | 1,400% |
FiEE (FIEE) | 2015 | 1,340.99% |
FingerMotion (FNGR) | 2015 | 940% |
Patriot National Bancorp (PNBK) | 2015 | 798.18% |
MDxHealth SA ADR (MDXH) | 2015 | 633.33% |
Anavex Life Sciences (AVXL) | 2015 | 632.89% |
Focus Universal (FCUV) | 2015 | 510.01% |
Dolphin Entertainment (DLPN) | 2015 | 471.43% |
Workhorse (WKHS) | 2015 | 406.54% |
authID (AUID) | 2015 | 380% |
Ambow Education (AMBO) | 2015 | 344.44% |
Celsius (CELH) | 2015 | 287.94% |
Exelixis (EXEL) | 2015 | 283.67% |
Galapagos NV ADR (GLPG) | 2015 | 231.72% |
Prothena (PRTA) | 2015 | 224.33% |
LightPath Technologies (LPTH) | 2015 | 211.23% |
Intellinetics (INLX) | 2015 | 200% |
Natural Health Trend (NHTC) | 2015 | 187.87% |
Energy Focu (EFOI) | 2015 | 186.46% |
eXp World (EXPI) | 2015 | 184.83% |
